Defective kinetics of cytochrome c oxidase and alteration of mitochondrial membrane potential in fibroblasts and cytoplasmic hybrid cells with the mutation for myoclonus epilepsy with ragged-red fibres ('MERRF') at position 8344 nt
Jazyk angličtina Země Anglie, Velká Británie Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
10477264
PubMed Central
PMC1220494
Knihovny.cz E-zdroje
- MeSH
- adenosintrifosfát biosyntéza MeSH
- fibroblasty enzymologie MeSH
- fluorescenční spektrometrie MeSH
- intracelulární membrány fyziologie MeSH
- kinetika MeSH
- lidé MeSH
- membránové potenciály fyziologie MeSH
- mutace MeSH
- oxidativní fosforylace MeSH
- průtoková cytometrie MeSH
- respirační komplex IV metabolismus MeSH
- separace buněk MeSH
- syndrom MERRF enzymologie genetika patologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- adenosintrifosfát MeSH
- respirační komplex IV MeSH
We have investigated pathogenic effects of the tRNA(Lys) A8344G mutation associated with the syndrome myoclonus epilepsy with ragged-red fibres (MERRF) by using fibroblasts and fibroblast-derived cytoplasmic hybrid cells harbouring different percentages of mutated mitochondrial DNA (mtDNA). The activity of cytochrome c oxidase (COX) in patient fibroblasts with 89% mutated mtDNA was decreased to 20% of the control levels. COX exhibited altered kinetics, with a decreased V(max) for both the low-affinity and high-affinity phases; however, the K(m) values were not significantly changed. The substrate-dependent synthesis of ATP was decreased to 50% of the control. Analysis of the mitochondrial membrane potential, DeltaPsi, in digitonin-treated cells with tetramethylrhodamine methyl ester (TMRM) with the use of flow cytometry showed a 80% decrease in DeltaPsi at state 4 and an increased sensitivity of DeltaPsi to an uncoupler in fibroblasts from the patient. The investigation of transmitochondrial cytoplasmic hybrid clones derived from the patient's fibroblasts enabled us to characterize the relationship between heteroplasmy of the MERRF mutation, COX activity and DeltaPsi. Within the range of 87-73% mutated mtDNA, COX activity was decreased to 5-35% and DeltaPsi was decreased to 6-78%. These results demonstrate that the MERRF mutation affects COX activity and DeltaPsi in different proportions with regard to mutation heteroplasmy and indicate that the biochemical manifestation of the MERRF mutation exerts a very steep threshold of DeltaPsi inhibition.
Zobrazit více v PubMed
Anal Biochem. 1976 May 7;72:248-54 PubMed
Eur J Pediatr. 1990 Apr;149(7):487-92 PubMed
Clin Chim Acta. 1985 Nov 29;153(1):37-42 PubMed
Biochem Biophys Res Commun. 1986 May 14;136(3):891-8 PubMed
Anal Biochem. 1987 Nov 1;166(2):368-79 PubMed
Eur J Biochem. 1988 Apr 5;173(1):1-8 PubMed
FEBS Lett. 1988 Aug 15;236(1):100-4 PubMed
Science. 1989 Oct 27;246(4929):500-3 PubMed
Cell. 1990 Jun 15;61(6):931-7 PubMed
Biochem Biophys Res Commun. 1990 Dec 14;173(2):561-5 PubMed
Am J Hum Genet. 1991 Feb;48(2):203-11 PubMed
Biochem Biophys Res Commun. 1991 Feb 14;174(3):1109-16 PubMed
Mol Cell Biol. 1991 Apr;11(4):2236-44 PubMed
Neurology. 1991 Apr;41(4):491-8 PubMed
Lancet. 1991 Jun 1;337(8753):1311-3 PubMed
Am J Hum Genet. 1991 Oct;49(4):715-22 PubMed
Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10614-8 PubMed
Anal Biochem. 1991 Nov 1;198(2):347-51 PubMed
Anal Biochem. 1991 Dec;199(2):223-31 PubMed
Am J Hum Genet. 1992 Dec;51(6):1187-200 PubMed
Am J Hum Genet. 1992 Dec;51(6):1201-12 PubMed
Am J Hum Genet. 1992 Dec;51(6):1213-7 PubMed
Biochim Biophys Acta. 1993 Apr 23;1167(3):345-50 PubMed
Brain. 1993 Jun;116 ( Pt 3):617-32 PubMed
J Clin Endocrinol Metab. 1993 Aug;77(2):382-7 PubMed
Muscle Nerve. 1994 Jan;17(1):52-7 PubMed
Acta Neurol Scand. 1993 Dec;88(6):406-9 PubMed
Mol Cell Biol. 1994 Apr;14(4):2699-712 PubMed
Am J Hum Genet. 1994 Jun;54(6):966-74 PubMed
Eur J Hum Genet. 1993;1(1):80-7 PubMed
Hum Mol Genet. 1994 Nov;3(11):1989-97 PubMed
Biochim Biophys Acta. 1995 Apr 24;1270(2-3):193-201 PubMed
Mol Cell Biol. 1995 May;15(5):2872-81 PubMed
Biochim Biophys Acta. 1995 May 24;1271(1):241-8 PubMed
Nat Genet. 1995 May;10(1):47-55 PubMed
Hum Mol Genet. 1995 Aug;4(8):1421-7 PubMed
Anal Biochem. 1995 Oct 10;231(1):218-24 PubMed
Biochim Biophys Acta. 1995 Dec 12;1272(3):190-8 PubMed
Hum Mol Genet. 1995 Nov;4(11):2017-23 PubMed
J Neurol Neurosurg Psychiatry. 1996 Jul;61(1):47-51 PubMed
Biochem J. 1996 Sep 1;318 ( Pt 2):401-7 PubMed
Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1166-71 PubMed
Muscle Nerve. 1997 Mar;20(3):271-8 PubMed
J Bioenerg Biomembr. 1997 Apr;29(2):131-49 PubMed
Acta Neurol Scand. 1997 Aug;96(2):65-71 PubMed
Brain. 1997 Oct;120 ( Pt 10):1713-21 PubMed
Am J Hum Genet. 1998 Apr;62(4):745-51 PubMed
J Biol Chem. 1951 Nov;193(1):265-75 PubMed
Anal Biochem. 1981 Nov 1;117(2):307-10 PubMed